Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Home
Search
Quick Search
Advanced
Fulltext
Browse
Collections
Persons
My eDoc
Session History
Login
Name:
Password:
Documentation
Help
Support Wiki
Direct access to
document ID:


          Institute: MPI für molekulare Genetik     Collection: Department of Computational Molecular Biology     Display Documents



  history
ID: 311244.0, MPI für molekulare Genetik / Department of Computational Molecular Biology
Gene-expression based classification of neuroblastoma patients using a customized oligonucleotide-microarray outperforms current clinical risk stratification
Authors:Oberthuer, André; Berthold, Frank; Warnat, Patrick; Hero, Barbara; Kahlert, Yvonne; Spitz, Rüdiger; Ernestus, Karen; König, Rainer; Haas, Stefan; Eils, Roland; Schwab, Manfred; Brors, Benedikt; Westermann, Frank; Fischer, Matthias
Language:English
Research Context:Supported by the Deutsche Krebshilfe (Grant No. 50-2719), the Bundesministerium für Bildung und Forschung through the National Genome Research Network 2 (NGFN2 Grants No. 01GS0456 and 01GR0450), the Competence Network Pediatric Oncology and Hematology, and the Fördergesellschaft Kinderkrebs-Neuroblastom-Forschung e.V.
Date of Publication (YYYY-MM-DD):2006-11-01
Title of Journal:Journal of Clinical Oncology : Jco ; Official Journal of the American Society of Clinical Oncology
Journal Abbrev.:J. Clin. Oncol.
Volume:24
Issue / Number:31
Start Page:5070
End Page:5078
Copyright:© 2006 American Society of Clinical Oncology.
Review Status:not specified
Audience:Experts Only
Abstract / Description:PURPOSE: To develop a gene expression–based classifier for neuroblastoma patients that reliably predicts courses of the disease.
PATIENTS AND METHODS: Two hundred fifty-one neuroblastoma specimens were analyzed using a customized oligonucleotide microarray comprising 10,163 probes for transcripts with differential expression in clinical subgroups of the disease. Subsequently, the prediction analysis for microarrays (PAM) was applied to a first set of patients with maximally divergent clinical courses (n = 77). The classification accuracy was estimated by a complete 10-times-repeated 10-fold cross validation, and a 144-gene predictor was constructed from this set. This classifier's predictive power was evaluated in an independent second set (n = 174) by comparing results of the gene expression–based classification with those of risk stratification systems of current trials from Germany, Japan, and the United States.
RESULTS: The first set of patients was accurately predicted by PAM (cross-validated accuracy, 99%). Within the second set, the PAM classifier significantly separated cohorts with distinct courses (3-year event-free survival [EFS] 0.86 ± 0.03 [favorable; n = 115] v 0.52 ± 0.07 [unfavorable; n = 59] and 3-year overall survival 0.99 ± 0.01 v 0.84 ± 0.05; both P < .0001) and separated risk groups of current neuroblastoma trials into subgroups with divergent outcome (NB2004: low-risk 3-year EFS 0.86 ± 0.04 v 0.25 ± 0.15, P < .0001; intermediate-risk 1.00 v 0.57 ± 0.19, P = .018; high-risk 0.81 ± 0.10 v 0.56 ± 0.08, P = .06). In a multivariate Cox regression model, the PAM predictor classified patients of the second set more accurately than risk stratification of current trials from Germany, Japan, and the United States (P < .001; hazard ratio, 4.756 [95% CI, 2.544 to 8.893]).
CONCLUSION: Integration of gene expression–based class prediction of neuroblastoma patients may improve risk estimation of current neuroblastoma trials.
External Publication Status:published
Document Type:Article
Version Comment:Automatic journal name synchronization
Communicated by:Martin Vingron
Affiliations:MPI für molekulare Genetik
External Affiliations:1.Department of Pediatric Oncology and Hematology, Children's Hospital; the Center for Molecular Medicine; Department of Pathology, University of Cologne, Cologne, Germany
2.Departments of Tumor Genetics (B030) and Theoretical Bioinformatics (B080), German Cancer Research Center, Heidelberg, Germany.
Identifiers:ISSN:1527-775
DOI:10.1200/JCO.2006.06.1879
The scope and number of records on eDoc is subject to the collection policies defined by each institute - see "info" button in the collection browse view.